Pharmacokinetic Considerations in the Treatment of CNS Tumours

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.45, Iss.9, 2006-01, pp. : 871-903

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Considerations in the Treatment of Childhood Epilepsy

By Gilman Jamie T.

Pediatric Drugs, Vol. 5, Iss. 4, 2003-01 ,pp. : 267-277

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease

By Schwab M. Klotz U.

Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. : 723-751

Adis International

Access to resources Recommend Favorite

Treatment of Anxiety and Depression in Transplant Patients: Pharmacokinetic Considerations

By Crone C.C.

Clinical Pharmacokinetics, Vol. 43, Iss. 6, 2004-01 ,pp. : 361-394

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Considerations in the Treatment of Tuberculosis in Patients with Renal Failure

By Launay-Vacher Vincent Izzedine Hassane Deray Gilbert

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 221-235

Adis International

Access to resources Recommend Favorite

Treatment of Epilepsy in Women of Reproductive Age: Pharmacokinetic Considerations

By McAuley J.W.

Clinical Pharmacokinetics, Vol. 41, Iss. 8, 2002-01 ,pp. : 559-579

Adis International

Access to resources Recommend Favorite